z-logo
Premium
Letter: when to withhold anti‐TNF agents prior to abdominal surgery in patients with Crohn’s disease—the jury might still be out. Authors’ reply
Author(s) -
Lin YangSheng,
Lin WeiChen,
Chen MingJen,
Wang YuanHung,
Chen Chiehfeng
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15398
Subject(s) - medicine , crohn's disease , disease , jury , abdominal surgery , crohn disease , tumor necrosis factor alpha , surgery , general surgery , pathology , law , political science

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom